Earnings call: Amicus Therapeutics reports robust Q3 growth, raises guidance By...

Published on 6 Nov 2024 on Investing.com

Amicus Therapeutics (NASDAQ: NASDAQ:FOLD) has reported a significant increase in revenue for the...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 17 Jan 2025

On November 6, Campbell sold 7,901 shares of common stock at an average price of $12.5048, totali...

Investing.com 8 Nov 2024

Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Amicus Therapeutics (NASDAQ: NASDAQ:FOLD) has reported a significant increase in revenue for the...

Investing.com 6 Nov 2024

Total Revenue: $127 million, a 34% increase year-over-year, or 36% on a constant currency basis....

GuruFocus.com · via Yahoo Finance 11 Oct 2024

We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have ...

Insider Monkey · via Yahoo Finance 24 Sep 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript May 9, 2024 Amicus Thera...

Insider Monkey via Yahoo Finance 8 May 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is possibly approaching a major achievement in its busine...

Simply Wall St. via Yahoo Finance 19 Apr 2024

Director Margaret Mcglynn has sold 15,000 shares of Amicus Therapeutics Inc (NASDAQ:FOLD) on Marc...

GuruFocus.com via Yahoo Finance 7 Mar 2024

Last week saw the newest full-year earnings release from Amicus Therapeutics, Inc. (NASDAQ:FOLD),...

Simply Wall St. via Yahoo Finance 2 Mar 2024